PD-128763

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NamePD-128763

Drug Alias NameN/A

ClassificationRadiation-emitting productsSmall molecules > Heterocyclic drugs

Mechanisms of ActionDNA repair enzymes inhibitorsPoly (ADP-Ribose) polymerase inhibitors

TargetsPoly (ADP-Ribose) polymeraseDNA repair enzymes

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A